CA9
genyn codio-protien yn y rhywogaeth Homo sapiens
Protein sy'n cael ei godio yn y corff dynol gan y genyn CA9 yw CA9 a elwir hefyd yn Carbonic anhydrase 9 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 9, band 9p13.3.[2]
CA9 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | |||||||||||||||||
| |||||||||||||||||
Dynodwyr | |||||||||||||||||
Cyfenwau | CA9, CAIX, MN, carbonic anhydrase 9 | ||||||||||||||||
Dynodwyr allanol | OMIM: 603179 HomoloGene: 20325 GeneCards: CA9 | ||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
Orthologau | |||||||||||||||||
Species | Bod dynol | Llygoden | |||||||||||||||
Entrez |
| ||||||||||||||||
Ensembl |
| ||||||||||||||||
UniProt |
| ||||||||||||||||
RefSeq (mRNA) |
| ||||||||||||||||
RefSeq (protein) |
| ||||||||||||||||
Lleoliad (UCSC) | n/a | n/a | |||||||||||||||
PubMed search | [1] | n/a | |||||||||||||||
Wicidata | |||||||||||||||||
|
Cyfystyron
golyguYn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn CA9.
- MN
- CAIX
Llyfryddiaeth
golygu- "Exosomes expressing carbonic anhydrase 9 promote angiogenesis. ". Biochem Biophys Res Commun. 2017. PMID 28851650.
- "Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells. ". Cancer Sci. 2017. PMID 28075522.
- "CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma. ". Biomarkers. 2017. PMID 27775441.
- "The Utility of Serum CA9 for Prognostication in Prostate Cancer. ". Anticancer Res. 2016. PMID 27630286.
- "Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial.". Radiother Oncol. 2016. PMID 27102843.